Organisation paid for research Program year 2024 Source: CMS Open Payments

ACRC Trials - Carrollton - Hunt - PPDS

Neither a doctor nor a teaching hospital

Research payments

$1,037,925

32 payments

Through program year 2024, ACRC Trials - Carrollton - Hunt - PPDS is reported as receiving $1,037,925 in research payments, across 32 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2024	Research	$526,749	12
2023	Research	$511,176	20

Breakdown

Who paid Research payments · program years 2023–2024

Moderna TX, Inc. $1,037,925 32 payments

Studies the money was for Research payments · program years 2023–2024

A Phase 2/3, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus (RSV), in Adults 60 Years of Age $972,867 18 payments
A Phase 1, Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 18- to 30-year-old Healthy Adults $28,296 6 payments
Observational secondary-use comparative effectiveness cohort study with tokenized clinical trial and real-world data. $23,450 4 payments
A Phase 1, Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 12- to 30-year-old Healthy Adolescents and Adults $13,313 4 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.